Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients.

Hurst FP, Jindal RM, Fletcher JJ, Dharnidharka V, Gorman G, Lechner B, Nee R, Agodoa LY, Abbott KC.

Urology. 2011 Jun;77(6):1271-6. doi: 10.1016/j.urology.2011.01.007. Epub 2011 Apr 3. Review.

PMID:
21459420
2.

Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.

Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T.

J Urol. 2005 Nov;174(5):1749-53.

PMID:
16217276
3.

Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience.

Hurst FP, Jindal RM, Graham LJ, Falta EM, Elster EA, Stackhouse GB, Agodoa LY, Lentine KL, Salifu MO, Abbott KC.

Transplantation. 2010 Oct 27;90(8):898-904. doi: 10.1097/TP.0b013e3181f30479.

PMID:
21248500
4.

Renal cell carcinoma in dialysis patients: a single center experience.

Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H.

Int J Urol. 2006 Aug;13(8):1045-8.

5.

Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.

Peces R, Martínez-Ara J, Miguel JL, Arrieta J, Costero O, Górriz JL, Picazo ML, Fresno M.

Nephrol Dial Transplant. 2004 Nov;19(11):2789-96. Epub 2004 Aug 17.

PMID:
15316098
6.

Thrombotic microangiopathy in United States long-term dialysis patients.

Perkins RM, Reynolds JC, Ahuja TS, Reid T, Agodoa LY, Bohen EM, Yuan CM, Abbott KC.

Nephrol Dial Transplant. 2006 Jan;21(1):191-6. Epub 2005 Oct 4.

PMID:
16204286
7.

[Renal lesions in tuberous sclerosis].

Schillinger F, Montagnac R.

Nephrol Ther. 2006 Jan;2 Suppl 2:S123-6. French.

PMID:
17373212
8.

Chronic renal failure and its treatment in tuberous sclerosis.

Schillinger F, Montagnac R.

Nephrol Dial Transplant. 1996 Mar;11(3):481-5.

PMID:
8671819
9.

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

Collins AJ, Hanson G, Umen A, Kjellstrand C, Keshaviah P.

Am J Kidney Dis. 1990 May;15(5):422-32.

PMID:
2333864
10.

Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.

Trivedi H, Xiang Q, Klein JP.

Nephrol Dial Transplant. 2009 Jan;24(1):258-66. doi: 10.1093/ndt/gfn426. Epub 2008 Aug 5.

PMID:
18682489
11.

Acquired cystic kidney disease: occurrence, prevalence, and renal cancers.

Matson MA, Cohen EP.

Medicine (Baltimore). 1990 Jul;69(4):217-26.

PMID:
2374506
12.

Renal cell carcinoma in native kidneys of patients with end stage renal disease.

Shingleton WB, Blalock J, Clark J, Bigler SA.

J Miss State Med Assoc. 1998 Mar;39(3):86-9.

PMID:
9538592
13.

Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.

Rabbani F, Russo P.

Urology. 1999 Jul;54(1):28-33.

PMID:
10414722
14.

Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations.

Hoshida Y, Nakanishi H, Shin M, Satoh T, Hanai J, Aozasa K.

Transplantation. 1999 Aug 15;68(3):385-90.

PMID:
10459542
15.

Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.

Kitiyakara C, Eggers P, Kopp JB.

Am J Kidney Dis. 2004 Nov;44(5):815-25.

PMID:
15492947
16.

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK.

N Engl J Med. 1999 Dec 2;341(23):1725-30.

17.

Risk for renal cell carcinoma in chronic hepatitis C infection.

Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1066-73. doi: 10.1158/1055-9965.EPI-09-1275. Epub 2010 Mar 23.

18.

Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.

Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y.

BJU Int. 2010 Mar;105(5):620-7. doi: 10.1111/j.1464-410X.2009.08817.x. Epub 2009 Aug 28.

19.

End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.

Bell M, Granath F, Schön S, Löfberg E; SWING, Ekbom A, Martling CR.

Crit Care Med. 2008 Oct;36(10):2773-8. doi: 10.1097/CCM.0b013e318187815a.

PMID:
18766088
20.

Supplemental Content

Support Center